Solgar Brand Leads First-Quarter NBTY Sales Growth
This article was originally published in The Tan Sheet
Executive Summary
NBTY's recently-acquired Solgar vitamin brand continues to drive the firm's sales, the company reported in a first-quarter earnings statement Jan. 9
You may also be interested in...
Wyeth earnings
Worldwide Consumer Healthcare net revenue was flat at $598 mil. during the second quarter, Wyeth announces July 20. Net revenue for the division worldwide during the first six months of 2006 decreased 5% to $1.16 bil. when compared to the first six months of 2005. An increase in sales of Advil and Centrum vitamins helped offset losses caused by lower sales of Robitussin, Dimetapp and Advil Cold & Sinus, which resulted from increased retailer restrictions on pseudoephedrine-containing products, the company says. The earnings also reflect the loss of Solgar vitamin sales; the brand was divested to NBTY in the third quarter of 2005 (1"The Tan Sheet" Jan. 16, 2006, p. 13). Wyeth Nutrition's second-quarter net revenue increased 13% over the prior-year period to $300 mil...
NBTY Sales Driven By Solgar; Firm Repositions Brand In Natural Food Channel
NBTY has started to reposition its newly acquired Solgar vitamin brand in the natural food and health segment by withdrawing the products from mass-market retailers
NBTY “Tough Quarter” Caused By Vitamin E Sales, Stalled Market - Rudolph
NBTY is predicting a rebound of the current stagnant supplement market as the baby boomer generation continues to enter the "vitamin age.